The Circadian Gene Clock Plays an Important Role in Cell Apoptosis and the DNA Damage Response In Vitro

Technology in Cancer Research and Treatment

Volumn 15, Issue 3, 2016, Pages 480-486

  Wang, Fan ^a   Li, Caiyan ^b   Yongluo, ^a   Chen, Lvan ^a  

^a First People's Hospital of Jingmen   (China)

^b The Second People's Hospital of Jingmen   (China)

Author keywords

clock; glioma; radiotherapeutic sensitivity

Indexed keywords

BETA ACTIN; CYCLIN D; MYC PROTEIN; PROTEIN P53; CLOCK PROTEIN, HUMAN; TRANSCRIPTION FACTOR CLOCK;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL CYCLE ARREST; CIRCADIAN RHYTHM; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; DOWN REGULATION; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN CELL; UPREGULATION; WESTERN BLOTTING; CELL TRANSFORMATION; GENE SILENCING; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; RADIATION RESPONSE; TUMOR CELL LINE;

APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; CLOCK PROTEINS; DNA DAMAGE; GENE KNOCKDOWN TECHNIQUES; GLIOMA; HUMANS;

EID: 84966534302     PISSN: 15330346     EISSN: 15330338     Source Type: Journal    
DOI: 10.1177/1533034615585433     Document Type: Article

References (38)

1. GuidoFrosina. DNA repair and resistance of gliomas to chemotherapy and radiotherapy. Mol Cancer Res. 2009;7(7):989–999.
2. H.OhgakiP.Kleihues. Genetic pathways to primary and secondary glioblastoma. Am J Pathol. 2007;170(5):1445–1453.
3. S.M.ReppertD.R.Weaver. Coordination of circadian timing in mammals. Nature. 2002;418(6901):935–941.
4. D.MorseC.P.Sassone. Time after time: inputs to and outputs from the mammalian circadian oscillators. Trends Neurosci. 2002;25(12):632–637.
5. A.C.CharlesF.D.JeanneL.S.Theresa. Stability, precision, and near-24-hour period of the human circadian pacemaker. Science. 1999;284(5423):217–281.
6. S.M.ReppertD.R.Weaver. Molecular analysis of mammalian circadian rhythms. Annu Rev Physiol. 2001;63:647–676.
7. K.F.StorchO.LipanI.Leykin. Extensive and divergent circadian gene expression in liver and heart. Nature. 2002;417(6884):78–83.
8. F.DelaunayV.Laudet. Circadian clock and microarrays: mammalian genome gets rhythm. Trends Genet. 2002;18(12):595–597.
9. P.M.RichardY.Q.XiaoL.BrianE.DavidW.P.Weston. Circadian clock and cell cycle gene expression in mouse mammary epithelial cells and in the developing mouse mammary gland. Dev Dyn. 2006;235(1):263–271.
10. T.MikiZ.XuM.C.Goodspeed. PML regulates PER2 nuclear localization and circadian function. EMBO J. 2012;31(6):1427–1439.
11. B.ZhengU.AlbrechtK.Kaasik. Nonredundant roles of the mPer1 and mPer2 genes in the mammalian circadian clock. Cell. 2001;105(5):683–694.
12. L.FuC.C.Lee. The circadian clock: pacemaker and tumour suppressor. Nat Rev Cancer. 2003;3(5):350–361.
13. Z.J.ChenP.LiuC.Li. Deregulated expression of the clock genes in gliomas. Technol Cancer Res Treat. 2013;12(1):91–97.
14. L.CanapleT.KakizawaV.Laudet. The days and nights of cancer cells. Cancer Res. 2003;63(22):7545–7552.
15. S.T.ChenK.B.ChooM.F.HouK.T.YehS.J.KuoJ.G.Chang. Deregulated expression of the PER1; PER2 and PER3 genes in breast cancers. Carcinogenesis. 2005;26(7):1241–1246.
16. Y.Y.MingC.Y.WenM.L.Pai. Altered expression of circadian clock genes in human chronic myeloid leukemia. J Biol Rhythms. 2011;26(2):136–148.
17. S.GeryR.K.VirkK.ChumakovA.YuH.P.Koeffler. The clock gene Per2 links the circadian system to the estrogen receptor. Oncogene. 2007;26(57):7916–7920.
18. H.HuaZ.WangC.Wan. Circadian gene mPer2 overexpression induces cancer cell apoptosis. Cancer Sci. 2006;97(7):589–596.
19. M.Y.YangY.C.LiuS.F.Lin. Downregulation of circadian clock genes in chronic myeloid leukemia: alternative methylation pattern of hPER3. Cancer Sci. 2006;97(12):1298–1307.
20. H.C.XiaZ.F.NiuH.Ma. Deregulated expression of the Per1 and Per2 in human gliomas. Can J Neurol Sci. 2010;37(3):365–370.
21. Min/+ tumorigenesis. Mol Cancer Res. 2008;6(11):1786–1793.
22. C.M.SunS.F.HuangJ.M.Zeng. Per2 inhibits K562 leukemia cell growth in vitro and in vivo through cell cycle arrest and apoptosis induction. Pathol Oncol Res. 2010;16(3):403–411.
23. S.FuyukiN.ChihiroL.Yang. PERIOD1 is an Anti-apoptotic factor in human pancreatic and hepatic cancer cells. J Biochem. 2009;146(6):833–838.
24. K.F.StorchO.LipanI.Leykin. Extensive and divergent circadian gene expression in liver and heart. Nature. 2002;417(6884):78–83.
25. G.E.DuffieldJ.D.BestB.H.MeurersA.BittnerJ.J.LorosJ.C.Dunlap. Circadian programs of transcriptional activation, signaling, and protein turnover revealed by microarray analysis of mammalian cells. Curr Biol. 2002;12(7):551–557.
26. B.KornmannN.PreitnerD.RifatO.F.FleuuryU.Schibler. Analysis of circadian liver gene expression by ADDER, a highly sensitive method for the display of differentially expressed mRNAs. Nucl Acids Res. 2001;29(11):E51–1.
27. M.N.LeF.DamiolaF.TroncheG.SchutzU.Schibler. Glucocorticoid hormones inhibit food-induced phase-shifting of peripheral circadian oscillators. EMBO J. 2001;20(24):7128–7136.
28. W.J.M.HrusheskyG.A.Bjarnason. Circadian cancer therapy. J Clin Oncol. 1993;11(7):1403–1417.
29. F.Levi. Circadian chronotherapy for human cancers. Lancet Oncol. 2001;2(5):307–315.
30. S.J.ClarkJ.Melki. DNA methylation and gene silencing in cancer: which is the guilty party?Oncogene. 2002;21(35):5380–5387.
31. K.T.YehM.Y.YangT.C.Liu. Abnormal expression of Period 1 (Per1) in endometrial carcinoma. J Pathol. 2005;206(1):111–120.
32. T.MatsuoS.YamaguchiS.MitsuiA.EmiF.ShimodaH.Okamura. Control mechanism of the circadian clock for timing of cell division in vivo. Science. 2003;302(5643):255–259.
33. L.FuH.PelicanoJ.LiuP.HuangC.Lee. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell. 2002;111(1):41–50.
34. G.MazzoccoliA.PiepoliM.Carell. Altered expression of the clock gene machinery in kidney cancer patients. Biomed Pharmacother. 2012;66(3):175–179.
35. Y.YardenM.X.Sliwkowski. Untangling the ErbB signalling network. Nat Rev Mol Cell Biol. 2001;2(2):127–137.
36. M.C.BrunoV.P.MartaF.Ricardo. Impact of EGFR Genetic Variants on Glioma Risk and Patient Outcome. Cancer Epidemiol Biomarkers Prev. 2011;20(12):2610–2617.
37. P.M.VianaJ.M.LopesS.Little. Analysis of EGFR overexpression, EGFR gene amplification and the EGFRvIII mutation in Portuguese high-grade gliomas. Anticancer Res. 2008;28(2A):913–920.
38. M.NomuraH.ShigematsuL.Li. Polymorphisms, mutations, and amplification of the EGFR gene in non-small cell lung cancers. PLoS Med. 2007;4(4):e125.